Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999–2010*

Schillie, Sarah; Xing, Jian; Murphy, Trudy V.; Hu, Dale J.

doi:10.1111/j.1365-2893.2012.01616.x

Cited by 48 publications

(53 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…20,21 It was seen that the prevalence of HBV infection was higher among persons with diabetes than without diabetes. 8 In different studies HBV sero-positivity was found 2-4% but in our study it was much higher. 22,23 The frequency of anti-HCV sero-positivity was lower in our study than two other studies.…”

Section: Discussioncontrasting

confidence: 42%

“…7 Chronic hepatitis B virus (HBV) infection is also significantly higher in diabetic population. 8,9 If inadequately addressed, the spectrum of NAFLD can pass through simple hepatic steatosis to nonalcoholic steatohepatitis (NASH) to cirrhosis to hepatocellular carcinoma and death. [10][11][12][13][14][15][16] In this study, we have tried to clinically evaluate adult newly detected impaired glucose tolerance (IGT) and diabetic patients with asymptomatic elevated ALT and to find out the aetiology for raised ALT.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Clinical and Biochemical Characteristics and Aetiology of Asymptomatic Raised Alanine Aminotransferase in Newly Detected Diabetes and Impaired Glucose Tolerance Patients

Rahman

Azam

Ali³

et al. 2016

J. Bangladesh Coll. Phys.

View full text Add to dashboard Cite

Objectives: Clinical evaluation and identification of aetiology of asymptomatic raised serum alanine aminotransferase (ALT) level in newly detected adult diabetic and impaired glucose tolerance (IGT) patients.Methods: In this cross-sectional study, newly detected adult diabetic and IGT patients having asymptomatic raised serum ALT level of > 1.5 times of upper limit of normal were evaluated clinically and by laboratory tests.Results: Total number of patients was 120, which was 3.1% of all newly registered diabetic and IGT patients over the study period. Male were 74 and female 46. Diabetes mellitus (DM) was found in 93.3% cases and IGT in 6.7%. Mean age was 43.1 years, mean body weight was 64.5 kg and mean body mass index (BMI) was 25.5 kg/m 2 . Central (abdominal) obesity was found in 61.5% cases. Increased waist hip ratio was found in 86.3% cases. Hypertension and hepatomegaly were present in 35% and 5.8% cases respectively. Dyslipidaemia was found in 98.3% cases and 45% patients fulfilled criteria for metabolic syndrome. Regarding etiology, 76.7% cases had non-alcoholic fatty liver disease (NAFLD), 8.3% had HBsAg sero-positivity, 4.2% had anti-HCV seropositivity and 3.3% had both NAFLD and HBsAg seropositivity. In 7.5% cases no cause was found. Raised serum ALT level had a significant correlation with metabolic syndrome (p= 0.016) and increasing age (p= 0.008). Conclusion

show abstract

Section: Discussioncontrasting

confidence: 42%

mentioning

confidence: 99%

Clinical and Biochemical Characteristics and Aetiology of Asymptomatic Raised Alanine Aminotransferase in Newly Detected Diabetes and Impaired Glucose Tolerance Patients

Rahman

Azam

Ali³

et al. 2016

J. Bangladesh Coll. Phys.

View full text Add to dashboard Cite

show abstract

“…8,9 The incidence of occult hepatitis B was significantly higher in patients with type 2 diabetes compared with the control group (11% vs 3%, respectively) 19 . Hepatitis B is a virus that can live for a long time on surfaces.…”

Section: Discussionmentioning

confidence: 99%

“…3 Particularly, hepatitis B infections require attention: hepatitis B prevalence and hepatitis B related hospital admissions were shown to be higher in diabetic patients. [8][9][10] American Advisory Committee on Immunization Practices recommended to vaccinate all diabetic patients aged 19-60 years against hepatitis B as soon as they are diagnosed with diabetes and to vaccinate those above 60 years after risk assessment in the 2011 update 11 . Standard dose vaccination should be carried out at months 0, 1 and 6.…”

Section: Introductionmentioning

confidence: 99%

Missed opportunities for Hepatitis B vaccination among diabetic patients

Özışık

Tanrıöver

Başaran

et al. 2015

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Many infectious diseases in adults can be prevented by a 'life-long vaccination strategy'. Hepatitis B disease burden was shown to be higher in diabetic patients. American Advisory Committee on Immunization Practices recommends to vaccinate diabetic patients against hepatitis B since 2011. In this study, we aimed to determine hepatitis B virus serology status to determine the rates of diabetic patients who have indications for hepatitis B vaccination. The electronic database of the hospital was searched to identify adult patients aged above 18 years and with hemoglobin A 1 C levels of 6.5% or above, who have been seen at General Medicine Outpatient Clinics of a university hospital during a 3-year period. A total of 5187 patients were included in the study. After exclusion of patients with an incomplete serological panel, 1358 patients were included for further analyses. Twenty-nine percent of the patients had indication for hepatitis B vaccination, whereas only 8% were vaccinated. This study showed that nearly one third of patients who had hepatitis B serological data had an indication for hepatitis B vaccination and this is a clear reflection of the need to keep a lifelong vaccination log and inquire vaccination data.

show abstract

“…Recent evidence show that hepatitis B infection occurs more frequently among individuals with type 2 diabetes than the general population [1][2][3]. The odds for developing acute hepatitis B for individuals with diabetes is said to be as much as twice that for non-diabetics.…”

Section: Introductionmentioning

confidence: 99%

Hepatitis B Vaccination Rate in Patients with Diabetes: Assessment of Racial and Socioeconomic Disparity

Aytaman¹,

Ojike²,

Samantha³

et al. 2016

Int J Clin Endocrinol Metab

View full text Add to dashboard Cite

Introduction: Less hygienic use of blood glucose monitoring equipment such as blood glucose meters, lancets, fi nger stick devices or other diabetes-care equipment such as syringes or insulin pens by self-administration often exposes the diabetic patient to Hepatitis B infection. This study evaluates hepatitis B vaccination among individuals with diabetes. Methods:The study used data from the 2000-2013 National Health Interview Survey (NHIS). Vaccination rates among adult individuals with diabetes of various ethnic backgrounds was accessed and compared using chis-square tests. Multivariable logistic regression model was used to compare factors affecting hepatitis B vaccination among individuals with diabetes. Results:The crude rate of diabetes in this population was 5.4%. The rate of vaccination among individuals with diabetes differed across racial groups (Asians 31.8% vs. blacks 30.7%; and whites 26.5%; p<0.01). After multivariate regression, the leading factors affecting hepatitis B vaccination included Age (40-60 years) (OR=0.51, 95% CI=0.47-0.57, p<0.01), lack of college education (OR=0.71,95% CI=0.64-0.79, p<0.01), foreign birth (OR=0.83, 95% CI=0.72-0.95, p<0.01) , and Hispanic ethnicity (OR=0.88, 95% CI=0.78-1.00, P<0.05). Conclusion:Social and economic factors-education, insurance status, age, poverty level, and place of birth affect rates of vaccination among individuals with diabetes.

show abstract

Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999–2010*

Cited by 48 publications

References 6 publications

Clinical and Biochemical Characteristics and Aetiology of Asymptomatic Raised Alanine Aminotransferase in Newly Detected Diabetes and Impaired Glucose Tolerance Patients

Clinical and Biochemical Characteristics and Aetiology of Asymptomatic Raised Alanine Aminotransferase in Newly Detected Diabetes and Impaired Glucose Tolerance Patients

Missed opportunities for Hepatitis B vaccination among diabetic patients

Hepatitis B Vaccination Rate in Patients with Diabetes: Assessment of Racial and Socioeconomic Disparity

Contact Info

Product

Resources

About